| Dr Jared Michael Radbel, MD | |
|
1 Robert Wood Johnson Pl, Meb 568, New Brunswick, NJ 08901-1928 | |
| (732) 235-7840 | |
| (732) 235-7048 |
| Full Name | Dr Jared Michael Radbel |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 17 Years |
| Location | 1 Robert Wood Johnson Pl, New Brunswick, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285926469 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Robert Wood Johnson University Hospital | New brunswick, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rutgers Health-rwj Scleroderma Program | 5193764991 | 291 |
News Archive
Harbour Antibodies BV, an Erasmus MC spin-off company, announced today the completion of a non-exclusive research and licence agreement with Eli Lilly and Company, a global pharmaceutical company, to generate and develop human therapeutic antibodies comprising immunoglobulin heavy and light chains(H2L2) using one of Harbour's transgenic mouse antibody discovery platforms.
"Pre-emptive treatment of children living in regions where malaria is prevalent only during the rainy season could avert 11 million cases and 50,000 deaths a year," the journal Nature reports, adding, "The estimates are based on the world's first guidance on seasonal malaria chemoprevention, issued by the World Health Organization (WHO) in March."
Sartorius Stedim Biotech, a leading international supplier for the biopharmaceutical industry today announced the launch of a new mini bioreactor vessel for its ambr 250 high throughput system.
"The Robert Wood Johnson Foundation initiated Cover the Uninsured Week so that millions of Americans could join together to say that the health care status quo in the United States, which leaves 44 million children, women and men without health insurance, is unacceptable, and that we cannot allow this situation to continue.
› Verified 9 days ago
| Entity Name | Rutgers Health-rwj Scleroderma Program |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679655781 PECOS PAC ID: 5193764991 Enrollment ID: O20050502000326 |
News Archive
Harbour Antibodies BV, an Erasmus MC spin-off company, announced today the completion of a non-exclusive research and licence agreement with Eli Lilly and Company, a global pharmaceutical company, to generate and develop human therapeutic antibodies comprising immunoglobulin heavy and light chains(H2L2) using one of Harbour's transgenic mouse antibody discovery platforms.
"Pre-emptive treatment of children living in regions where malaria is prevalent only during the rainy season could avert 11 million cases and 50,000 deaths a year," the journal Nature reports, adding, "The estimates are based on the world's first guidance on seasonal malaria chemoprevention, issued by the World Health Organization (WHO) in March."
Sartorius Stedim Biotech, a leading international supplier for the biopharmaceutical industry today announced the launch of a new mini bioreactor vessel for its ambr 250 high throughput system.
"The Robert Wood Johnson Foundation initiated Cover the Uninsured Week so that millions of Americans could join together to say that the health care status quo in the United States, which leaves 44 million children, women and men without health insurance, is unacceptable, and that we cannot allow this situation to continue.
› Verified 9 days ago
| Entity Name | Rutgers Health-rwj Pulmonary |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275563611 PECOS PAC ID: 7315989563 Enrollment ID: O20050526000992 |
News Archive
Harbour Antibodies BV, an Erasmus MC spin-off company, announced today the completion of a non-exclusive research and licence agreement with Eli Lilly and Company, a global pharmaceutical company, to generate and develop human therapeutic antibodies comprising immunoglobulin heavy and light chains(H2L2) using one of Harbour's transgenic mouse antibody discovery platforms.
"Pre-emptive treatment of children living in regions where malaria is prevalent only during the rainy season could avert 11 million cases and 50,000 deaths a year," the journal Nature reports, adding, "The estimates are based on the world's first guidance on seasonal malaria chemoprevention, issued by the World Health Organization (WHO) in March."
Sartorius Stedim Biotech, a leading international supplier for the biopharmaceutical industry today announced the launch of a new mini bioreactor vessel for its ambr 250 high throughput system.
"The Robert Wood Johnson Foundation initiated Cover the Uninsured Week so that millions of Americans could join together to say that the health care status quo in the United States, which leaves 44 million children, women and men without health insurance, is unacceptable, and that we cannot allow this situation to continue.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jared Michael Radbel, MD 1 Robert Wood Johnson Pl, Meb 568, New Brunswick, NJ 08901-1928 Ph: (732) 235-7840 | Dr Jared Michael Radbel, MD 1 Robert Wood Johnson Pl, Meb 568, New Brunswick, NJ 08901-1928 Ph: (732) 235-7840 |
News Archive
Harbour Antibodies BV, an Erasmus MC spin-off company, announced today the completion of a non-exclusive research and licence agreement with Eli Lilly and Company, a global pharmaceutical company, to generate and develop human therapeutic antibodies comprising immunoglobulin heavy and light chains(H2L2) using one of Harbour's transgenic mouse antibody discovery platforms.
"Pre-emptive treatment of children living in regions where malaria is prevalent only during the rainy season could avert 11 million cases and 50,000 deaths a year," the journal Nature reports, adding, "The estimates are based on the world's first guidance on seasonal malaria chemoprevention, issued by the World Health Organization (WHO) in March."
Sartorius Stedim Biotech, a leading international supplier for the biopharmaceutical industry today announced the launch of a new mini bioreactor vessel for its ambr 250 high throughput system.
"The Robert Wood Johnson Foundation initiated Cover the Uninsured Week so that millions of Americans could join together to say that the health care status quo in the United States, which leaves 44 million children, women and men without health insurance, is unacceptable, and that we cannot allow this situation to continue.
› Verified 9 days ago
Jennifer Waldmann, M.D Internal Medicine Medicare: Medicare Enrolled Practice Location: 254 Easton Ave, New Brunswick, NJ 08901 Phone: 732-996-6741 | |
Lokesh Lahoti, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Robert Wood Johnson Pl, New Brunswick, NJ 08901 Phone: 732-823-3000 | |
Dr. Imran Khan, M.D., PH.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 125 Paterson St, Suite 5200, New Brunswick, NJ 08901 Phone: 732-235-6531 | |
Dr. Robert Louis Wong, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 125 Paterson St Ste 5100, New Brunswick, NJ 08901 Phone: 732-235-6583 Fax: 732-235-7238 | |
Eric A Rubin, Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 195 Little Albany St, New Brunswick, NJ 08901 Phone: 732-235-2465 | |
Haris Ishaque Rana, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 240 Easton Ave, New Brunswick, NJ 08901 Phone: 732-745-8564 Fax: 732-745-9156 | |
Amanda Borham, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Robert Wood Johnson Pl, New Brunswick, NJ 08901 Phone: 732-235-7794 Fax: 732-235-7238 |